GI Oncology
Feature
CRC screening guidelines: 45 is the new 50, and 85 is the new 75
Multiple guidelines, levels of evidence, different screening methods with varying efficacy, individual risk factors - how can clinicians make...
From the Journals
Does surgery for colorectal liver metastases release tumor cells?
Feature
First AI device for colonoscopy: Extra set of expert ‘eyes’
The GI Genius device, when combined with colonoscopy, enhances provider performance and reduces colon cancer risk by increasing adenoma detection...
News from the FDA/CDC
FDA approves frontline immunotherapy for gastric cancers
Nivolumab is now approved for the frontline treatment of advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal...
Conference Coverage
Cumulative inflammatory burden predicts cancer risk in ulcerative colitis
Second study validates cumulative microscopic inflammation score as independent predictor of colorectal neoplasia.
Feature
Swallowable capsule-camera may reveal GI cancers, diseases
Conference Coverage
Can smoke exposure inform CRC surveillance in IBD?
A prospective analysis showed heightened risk for colorectal neoplasia in some subgroups, but the analysis didn’t account for inflammation.
From the Journals
Age should not be a barrier to aggressive esophageal cancer treatment
Comorbidities, fitness are what matters.
From the Journals
ASCO announces new advanced liver cancer guidelines
The American Society of Clinical Oncology announced new guidelines for systemic therapy of advanced hepatocellular carcinoma.
Article
Nanoparticle encapsulation may unlock HCC therapy
The investigators turned to nanoparticles, which accumulate in tumor tissue more than healthy tissue, thereby limiting off-target toxicity.
From the Journals
Color-imaging endoscopy improves detection of upper GI cancer
Neoplastic lesions were detected in 60 patients (8%) with LCI versus 36 patients (4.8%) with WLI, which translated to a 1.67 times higher rate of...